CASI Pharmaceuticals (CASIF) Divestments (2022)
CASI Pharmaceuticals' (CASIF) quarterly Divestments came in at $2.5 million in Q4 2022.
CASI Pharmaceuticals (CASIF) Divestments (2022) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 1 years of Divestments data on file, last reported at $2.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | -13.21 Mn |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.50 Mn |